| Financial Year |
March 31 2023 |
| Monetary Funds |
369,482,264.73 |
| Held-for-trading Financial Assets |
136,230,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
55,846,969.69 |
| Advances to Suppliers |
8,280,232.65 |
| Other Receivables |
48,349,465.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
173,096,128.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
923,874.91 |
| Total Current Assets |
792,208,935.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
344,592,280.17 |
| Under-construction Projects |
82,092,325.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
104,682,697.71 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,752,973.02 |
| Deferred Income Tax Assets |
2,326,887.43 |
| Other Non-Current Assets |
23,113,438.41 |
| Sub-Total of Non-Current Assets |
595,189,389.69 |
| Total Assets |
1,387,398,325.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
39,837,677.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,340,057.86 |
| Taxes Payable |
5,338,500.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,387,451.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,458,363.51 |
| Other Current Liabilities |
1,097,828.78 |
| Sub-Total of Current Liabilities |
83,498,365.81 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
992,211.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,214,118.49 |
| Total Liabilities |
89,712,484.30 |
| Paid-In Capital(Or Share Stock) |
237,024,000.00 |
| Capital Surplus |
548,701,593.07 |
| Surplus Reserve |
51,516,042.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
460,243,389.35 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,297,685,840.70 |
| Owner's Equity（Stockholder's Equity） |
1,297,685,840.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,387,398,325.00 |
